TRIMODAL PREHABILITATION IN GASTROINTESTINAL CANCER
Recruiting
N/A
Interventional Study
Digestive Neoplasms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 30 (estimated)
- Sponsor
- Puerta de Hierro University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Digestive cancers account for a substantial proportion of oncological patients, representing over 20% of cases treated in hospitals, and are generally managed through a multidisciplinary approach that has markedly improved survival outcomes over recent decades. Surgical resection remains the cornerstone of curative treatment, often preceded by neoadjuvant chemotherapy, radiotherapy, or combined mo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* More than 18 years old
* ECOG 0-2
* Being able to complete the mile-time test
* Stages I-III
* Being able to understand the informed consent
* Gastrointestinal cancer diagnosed
Exclusion Criteria:
* Metastatic cancer
Contacts